LISA HASLAG: Open Payments
NPI 1679071625 · COLUMBIA, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,308 in 69 payments from 13 companies in 2025. Trend: 2023 $1,929 · 2024 $1,253 · 2025 $1,308
Food & beverage: $1,243Education: $65
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 18 | $437 |
| Novartis Pharmaceuticals Corporation | 15 | $323 |
| ABBVIE INC. | 22 | $246 |
| PFIZER INC. | 3 | $67 |
| Amgen Inc. | 2 | $46 |
| Mallinckrodt Hospital Products Inc. | 2 | $41 |
| LEO Pharma Inc. | 1 | $27 |
| Regeneron Healthcare Solutions, Inc. | 1 | $25 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 1 | $24 |
| UCB, Inc. | 1 | $24 |
Products named: TREMFYA, COSENTYX, SKYRIZI, RINVOQ, Rhapsido, CIBINQO, ACTHAR, OTEZLA.
Industry payments across MO — which companies pay providers there.
